How should microemulsified Cyclosporine A (Neoral) therapy in patients with nephrotic syndrome be monitored?

Nephrol Dial Transplant. 2005 Jun;20(6):1032-4. doi: 10.1093/ndt/gfh803. Epub 2005 Apr 6.
No abstract available

Publication types

  • Editorial
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Area Under Curve
  • Child
  • Cyclosporine / administration & dosage
  • Cyclosporine / blood
  • Cyclosporine / pharmacokinetics*
  • Cyclosporine / therapeutic use
  • Female
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / blood
  • Immunosuppressive Agents / pharmacokinetics*
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Monitoring, Physiologic
  • Nephrotic Syndrome / drug therapy*

Substances

  • Immunosuppressive Agents
  • Cyclosporine